SEC Form D filing

Contraline Mar 2026 a Series of CGF2021 LLC

Biotech · Seed · Regulation D 506(b) · DE · Filed May 28, 2026

Offering amount: $275.0K
Exemption: Reg D 506(b)
Issuer state: DE
Filing date: May 28, 2026
Signature date: May 28, 2026
CIK: 0002127133

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: May 2026 Stage and month: Seed

Summary

Auto-generated

Contraline Mar 2026 SPV; contraception/reproductive health focus suggests biotech; $275K seed-stage offering.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.